276 related articles for article (PubMed ID: 18390458)
1. Adherence to oral endocrine therapy for breast cancer: a nursing perspective.
Miaskowski C; Shockney L; Chlebowski RT
Clin J Oncol Nurs; 2008 Apr; 12(2):213-21. PubMed ID: 18390458
[TBL] [Abstract][Full Text] [Related]
2. Adherence to endocrine therapy for breast cancer.
Chlebowski RT; Geller ML
Oncology; 2006; 71(1-2):1-9. PubMed ID: 17344666
[TBL] [Abstract][Full Text] [Related]
3. Improving compliance and persistence to adjuvant tamoxifen and aromatase inhibitor therapy.
Hadji P
Crit Rev Oncol Hematol; 2010 Feb; 73(2):156-66. PubMed ID: 19299162
[TBL] [Abstract][Full Text] [Related]
4. Sequential therapy with tamoxifen and aromatase inhibitors in early-stage postmenopausal breast cancer: a review of the evidence.
Litsas G
Oncol Nurs Forum; 2008 Jul; 35(4):714-21. PubMed ID: 18591176
[TBL] [Abstract][Full Text] [Related]
5. Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy.
Cella D; Fallowfield LJ
Breast Cancer Res Treat; 2008 Jan; 107(2):167-80. PubMed ID: 17876703
[TBL] [Abstract][Full Text] [Related]
6. Effectively nursing patients receiving aromatase inhibitor therapy.
Wengström Y
Breast; 2008 Jun; 17(3):227-38. PubMed ID: 18077168
[TBL] [Abstract][Full Text] [Related]
7. Nonadherence in patients with breast cancer receiving oral therapies.
Moore S
Clin J Oncol Nurs; 2010 Feb; 14(1):41-7. PubMed ID: 20118025
[TBL] [Abstract][Full Text] [Related]
8. Hormonal breast cancer agents: implications for the primary care provider.
Lyon DE; Roux G; Voll S
J Am Acad Nurse Pract; 2006 Nov; 18(11):518-23. PubMed ID: 17064329
[TBL] [Abstract][Full Text] [Related]
9. Oncologist-patient discussion of adjuvant hormonal therapy in breast cancer: results of a linguistic study focusing on adherence and persistence to therapy.
Davidson B; Vogel V; Wickerham L
J Support Oncol; 2007 Mar; 5(3):139-43. PubMed ID: 17410813
[TBL] [Abstract][Full Text] [Related]
10. Aromatase inhibitor agents in breast cancer: evolving practices in hormonal therapy treatment.
Viale PH
Oncol Nurs Forum; 2005 Mar; 32(2):343-53. PubMed ID: 15759071
[TBL] [Abstract][Full Text] [Related]
11. Bisphosphonate therapy for metastatic bone disease: the pivotal role of nurses in patient education.
Fitch MI; Maxwell C
Oncol Nurs Forum; 2008 Jul; 35(4):709-13. PubMed ID: 18591175
[TBL] [Abstract][Full Text] [Related]
12. Challenges of oral medications in patients with advanced breast cancer.
Palmieri FM; Barton DL
Semin Oncol Nurs; 2007 Nov; 23(4 Suppl 2):S17-22. PubMed ID: 18054678
[TBL] [Abstract][Full Text] [Related]
13. Oral chemotherapy medications: the need for a nurse's touch.
Winkeljohn DL
Clin J Oncol Nurs; 2007 Dec; 11(6):793-6. PubMed ID: 18063536
[TBL] [Abstract][Full Text] [Related]
14. Aromatase inhibitor-induced arthralgia: clinical experience and treatment recommendations.
Coleman RE; Bolten WW; Lansdown M; Dale S; Jackisch C; Merkel D; Maass N; Hadji P
Cancer Treat Rev; 2008 May; 34(3):275-82. PubMed ID: 18082328
[TBL] [Abstract][Full Text] [Related]
15. Patient education: the cornerstone of successful oral chemotherapy treatment.
Hartigan K
Clin J Oncol Nurs; 2003; 7(6 Suppl):21-4. PubMed ID: 14705496
[TBL] [Abstract][Full Text] [Related]
16. The alphabet soup of chemotherapy.
Dinman S
Plast Surg Nurs; 2007; 27(3):173-5. PubMed ID: 17901830
[No Abstract] [Full Text] [Related]
17. Adjuvant endocrine therapy for perimenopausal women with early breast cancer.
Ortmann O; Cufer T; Dixon JM; Maass N; Marchetti P; Pagani O; Pronzato P; Semiglazov V; Spano JP; Vrdoljak E; Wildiers H
Breast; 2009 Feb; 18(1):2-7. PubMed ID: 19036588
[TBL] [Abstract][Full Text] [Related]
18. [The role of the nurse in encouraging compliance in dialysis patients].
Lethuillier V
Soins; 2010 May; (745):35-6. PubMed ID: 20509489
[TBL] [Abstract][Full Text] [Related]
19. [Hormonal therapy in breast cancer].
Espinós J; Reyna C; de la Cruz S; Oiler C; Hernández A; Fernández Hidalgo O; Santisteban M; García Foncillas J
Rev Med Univ Navarra; 2008; 52(1):40-8. PubMed ID: 18578196
[TBL] [Abstract][Full Text] [Related]
20. Aromatase inhibitors as adjuvant therapy for breast cancer: overall survival versus disease-free survival as a primary end point in clinical practice.
Sánchez-Muñoz A; Ribelles N; Márquez A; Pérez-Ruiz E; Alba E
J Clin Oncol; 2009 Dec; 27(35):e255-6; author reply e257-8. PubMed ID: 19884520
[No Abstract] [Full Text] [Related]
[Next] [New Search]
